Dyspepsia clinical trials

Explore recruiting dyspepsia clinical trials.

Recruiting dyspepsia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dyspepsia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Budesonide as a treatment for low-grade duodenal inflammation in functional dyspepsia.

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

A Randomized, Non-inferiority Trial Comparing 7-Day Versus 4-Week Esomeprazole Treatment in Patients with Unexplained Dyspepsia

Iceland

Therapeutic use (Phase IV) EU CTIS Study details

A randomized controlled trial of Rikkunshito (TJ-43) in Functional Dyspepsia patients recruited from primary care.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of the effectiveness and safety of ALKACITRAT® on the treatment of functional dyspepsia

Greece

Therapeutic use (Phase IV) EU CTIS Study details

Randomised, placebo-controlled clinical trial on the efficacy of Roleca® juniper 100 mg for dyspeptic digestive complaints such as cramps in the gastrointestinal tract, flatulence and bloating.

Germany

Therapeutic use (Phase IV) EU CTIS Study details

Determining the optimal strategy for stopping chronic proton pump inhibitor therapy in primary care patients: impact of on-demand use, adjustment of therapy or discontinuation.

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Dyspepsia trials by city

Dyspepsia in Toronto Dyspepsia in Vancouver Dyspepsia in Montreal Dyspepsia in Calgary Dyspepsia in Edmonton Dyspepsia in Ottawa Dyspepsia in Winnipeg Dyspepsia in Quebec City Dyspepsia in Hamilton Dyspepsia in Kitchener Dyspepsia in London Dyspepsia in Halifax Dyspepsia in New York Dyspepsia in Los Angeles Dyspepsia in Chicago Dyspepsia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease